GE HealthCare announces the renewal of its research partnership with Stanford Medicine, notably focused on the development of innovative whole-body PET/CT technology.

This collaboration aims to explore new clinical avenues and improve patient outcomes through advanced imaging solutions.

PET/CT technology enables visualization of biological processes at the cellular level. Its whole-body version could speed up examinations, reduce the doses injected, and pave the way for more accurate diagnoses, particularly in oncology, cardiology, and neurology.

According to Dr. Quynh-Thu Le of Stanford, this innovation could "transform translational research."


Copyright (c) 2025 CercleFinance.com. All rights reserved.